Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Drug Delivery Systems: Different Types

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Drug Delivery: Overview

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...

Modified-Release Drug Delivery Systems: Overview

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lanthanum triflate catalysed acyl transfer from β-diketones to amines: conversion of aryl methyl ketones to amides.

RSC advances·2026

Same author

Regional ventilation-perfusion changes after endobronchial valve therapy assessed by single-photon emission computed tomography in adults with severe COPD.

Scientific reports·2026

Same author

Multistage feature selection and stacked generalization model for cancer detection.

Scientific reports·2025

Same author

Conversion of aromatic methyl ketones to esters and carboxylic acids using <i>o</i>-phthalaldehyde as an oxidant.

Organic & biomolecular chemistry·2024

Same author

Intratumoural haemorrhage in intracranial germ cell tumours: A review of literature with an illustrative case.

World neurosurgery: X·2024

Same author

Subdural hemorrhage in middle cranial fossa arachnoid cysts: a report of two cases at two ends of the spectrum.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2023

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

Multimodal drug delivery using gold nanoparticles.

Chae-kyu Kim¹, Partha Ghosh, Vincent M Rotello

¹Department of Chemistry, University of Massachusetts, Amherst, MA 01003, USA.

|July 21, 2010

Summary

This summary is machine-generated.

Gold nanoparticles (AuNPs) offer a versatile platform for drug delivery due to their biocompatibility and tunable properties. This review explores strategies leveraging AuNPs as nanocarriers for enhanced therapeutic applications.

More Related Videos

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Related Experiment Videos

Last Updated: Jun 10, 2026

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Area of Science:

Nanotechnology
Materials Science
Biomedical Engineering

Background:

Gold nanoparticles (AuNPs) are increasingly recognized for their potential in nanomedicine.
Their synthesis is straightforward, and they exhibit excellent biocompatibility and low toxicity.
Surface functionalization allows for tailored properties and targeted delivery.

Purpose of the Study:

To review strategies for utilizing gold nanoparticles in drug delivery.
To highlight the advantages of AuNPs as nanocarriers.
To discuss the versatility and tunability of AuNP properties for therapeutic applications.

Main Methods:

Literature review of existing research on gold nanoparticles for drug delivery.
Analysis of chemical and physical properties of AuNPs relevant to drug encapsulation and release.
Discussion of various functionalization and delivery strategies.

Main Results:

Gold nanoparticles demonstrate facile synthesis and ease of functionalization.
Their unique monolayer properties offer versatile delivery methods and tunable surface characteristics.
AuNPs present inherent biocompatibility and non-toxicity, making them suitable for therapeutic use.

Conclusions:

Gold nanoparticles are highly promising nanocarriers for drug delivery systems.
Their adaptable nature allows for diverse therapeutic applications.
Further research into AuNP-based drug delivery strategies is warranted.